These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3092589

  • 21. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ, Burnand KG.
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract] [Full Text] [Related]

  • 22. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S, Akaza H, Ohashi Y, Kotake T.
    Cancer; 1999 Nov 01; 86(9):1818-26. PubMed ID: 10547556
    [Abstract] [Full Text] [Related]

  • 23. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1988 Nov 01; 12(5):419-23. PubMed ID: 3218579
    [No Abstract] [Full Text] [Related]

  • 24. Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder cancer.
    Vera-Donoso CD, Llopis B, Oliver F, Gallego J, Ruiz J, Vidal J, Jiménez Cruz JF.
    Eur Urol; 1990 Nov 01; 17(3):219-22. PubMed ID: 2112473
    [Abstract] [Full Text] [Related]

  • 25. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK, Sen DK.
    J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360
    [No Abstract] [Full Text] [Related]

  • 26. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
    Anton-Aparicio LM, Urmeneta J, Borras M, Balaguer R, Berián JM.
    Actas Urol Esp; 1985 Nov 01; 9(6):517-22. PubMed ID: 3938597
    [No Abstract] [Full Text] [Related]

  • 27. [Local chemotherapy in vesical neoplasms].
    Pavone-Macaluso M, Caramia G, Rizzo FP.
    J Radiol Electrol Med Nucl; 1974 Nov 01; 55(11):844-8. PubMed ID: 4217830
    [No Abstract] [Full Text] [Related]

  • 28. Intravesical treatment with thiotepa: an update review.
    Fosså SD.
    Prog Clin Biol Res; 1984 Nov 01; 162B():163-8. PubMed ID: 6438640
    [No Abstract] [Full Text] [Related]

  • 29. [Progress in the internist treatment of bladder tumors].
    Baumgartner G.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):305-12. PubMed ID: 6814073
    [Abstract] [Full Text] [Related]

  • 30. Recurrence prophylaxis of bladder cancer.
    Pavone-Macaluso M.
    Ann Chir Gynaecol; 1984 Jul 31; 73(4):243. PubMed ID: 6508205
    [No Abstract] [Full Text] [Related]

  • 31. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A, Santos García Vaquero I, Polo Villar G, Díaz González R, González Martín M, Zuloaga Gómez A, Martínez Torres JL, Rodríguez Alvarez J, Duarte Vázquez JJ, Megino López JF.
    Arch Esp Urol; 1984 Jul 31; 37(2):113-22. PubMed ID: 6431914
    [No Abstract] [Full Text] [Related]

  • 32. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H, Yokota K, Kurokawa Y, Kagawa S, Yokozeki H, Inai T, Ogawa I, Akazawa S, Hashimoto H, Mizuta K.
    Gan To Kagaku Ryoho; 1999 Apr 31; 26(5):651-5. PubMed ID: 10234296
    [Abstract] [Full Text] [Related]

  • 33. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G, Mellin P.
    Z Urol Nephrol; 1973 Aug 31; 66(8):569-72. PubMed ID: 4204011
    [No Abstract] [Full Text] [Related]

  • 34. Chemoprevention of superficial bladder cancer.
    Kamat AM.
    Expert Rev Anticancer Ther; 2003 Dec 31; 3(6):799-808. PubMed ID: 14686702
    [Abstract] [Full Text] [Related]

  • 35. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988 Dec 31; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 36. Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study.
    Fosså SD, Miller A, Stenwig AE.
    Eur Urol; 1983 Dec 31; 9(4):207-10. PubMed ID: 6409615
    [Abstract] [Full Text] [Related]

  • 37. [Prevention of recurrence in non-invasive bladder carcinoma. Experiences with 400 patients].
    Burk K, Troller RM, Pittner P.
    Urologe A; 1983 Sep 31; 22 Suppl():332-6. PubMed ID: 6356556
    [Abstract] [Full Text] [Related]

  • 38. Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa.
    Prout GR, Koontz WW, Coombs LJ, Hawkins IR, Friedell GH.
    J Urol; 1983 Oct 31; 130(4):677-80. PubMed ID: 6411939
    [Abstract] [Full Text] [Related]

  • 39. [Intravesical instillation of doxorubicin or epirubicin for chemoprophylaxis of superficial bladder cancer--the fifth study of the Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin].
    Hinotsu S, Akaza H, Isaka S, Kagawa S, Koiso K, Kotake T, Machida T, Matsumura Y, Niijima T, Obata K, Ohashi Y, Ohe H, Shimazaki J, Tashiro K, Japanese Urological Cancer Research Group for Adriamycin/Farumorubicin.
    Gan To Kagaku Ryoho; 2002 Jan 31; 29(1):73-80. PubMed ID: 11816482
    [Abstract] [Full Text] [Related]

  • 40. [Toxicity of prophylaxis of superficial bladder tumors].
    Ojea Calvo A, Nogueira March JL, Alonso A, Verez M, Rodríguez Iglesias B, Benavente J, Barros JM.
    Actas Urol Esp; 1994 Jan 31; 18(7):714-22. PubMed ID: 7942230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.